Ilia Tikhomirov

Founder of 35Pharma

Ilia Tikhomirov

Backed by

Sources

35Pharma Announces Clearance of Clinical Trial Application for HS135, Best-in-Class Activin and GDF Inhibitor — 2024-11

Browse all founders · Browse investors